Otonomy's ear drug fails mid-stage trial, shares slide

(Reuters) - Otonomy Inc said its experimental drug did not meet the main goal of reducing the incidence of vertigo in a mid-stage trial in patients suffering from Ménière's disease.

Source: Reuters: Health - May 21, 2015 Category: Consumer Health News Tags: healthNews Source Type: news